The challenges of manufacturing inhalation products at commercial scale

Industrialising inhalation products requires specialist knowledge, a comprehensive manufacturing strategy and comprehensive product maintenance in order to overcome potential hurdles during commercial scale production.

A well thought through manufacturing strategy is key to overcoming hurdles during the scale-up and industrialisation of inhalation products.

To this end, drug developers often outsource their commercial manufacturing requirements to contract development and manufacturing organisations (CDMOs) to reduce internal capacity constraints and effectively navigate the manufacturing of a product from small to large scale.

Robin Heath, Commercial Manager and Head of Supply Chain, at Recipharm explores the key challenges companies face during the industrialisation of inhalation products and outlines how these hurdles can be overcome.

Read the full article here on pg 20 - 21: https://bit.ly/2KKLM3v